HOME >> BIOLOGY >> NEWS
JCI table of contents, 15 June 2004

Small RNA Surmounts Large Cancer Problem

Many potentially effective cancer treatments are undone by the onset of resistance to the treatment. In order to circumvent this problem, D. Gary Gilliland and colleagues, of Brigham and Women's Hospital, have developed a strategy using the latest technologies involving small interfering RNA to enhance cancer treatment even in a situation where drug resistance has developed. Small interfering RNAs work by inhibiting the expression of specific genes that have a matching complimentary sequence. The authors theorized that this type of RNA treatment might boost the effectiveness of anti-cancer treatments. They tested their theory in a form of leukemia that is caused when two genes fuse to form an unregulated gene that transforms normal cells into cancer cells, a gene called TEL-PDGFbetaR. This form of leukemia is generally treated with a commonly used anti-cancer drug called imatinib, which is a small molecule protein inhibitor that blocks the activity of the protein produced from the fusion gene TEL-PDGFbetaR. Gilliland and colleagues created a small inhibitory RNA specific to the TEL-PDGFbetaR fusion gene, and found that its expression did indeed exclusively reduce the expression of the oncogenic TEL-PDGFbetaR by 90%. While this alone was not sufficient to kill the cancer cells, this treatment enhanced the ability of imatinib to kill these cancer cells. Further, when they tested this strategy with imatinib-resistant cells, the inhibitory RNA was still able to reduce this gene's expression, and enhanced the activity of another small molecule inhibitor. This study demonstrates that small inhibitory RNA treatment may be an extremely useful adjunct to cancer treatments, and can also aid in overcoming the common problem of drug resistance when used in conjunction with anticancer agents.

TITLE: Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin


'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Jun-2004


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 1 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... WESTBURY, N.Y. (PRWEB) , ... April 28, 2020 ... ... clients, these webinars are Lachman Consultants latest effort in providing timely and critical ... environment, further complicated by social distancing and health safety concerns. , “Providing the ...
(Date:4/23/2020)... ... April 23, 2020 , ... Despite ... MDG provides critical infrastructure products for the animal feed, human consumption, wastewater, and ... expansion. Further, as supply channels from overseas competitors have become weakened or shut ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world leader ... will present a company update on its work expediting gene therapy research and advancing ... April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also provide ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... 2020 , ... ProductLife Group has marked the next phase in ... after 13 years at Altran, where he was Group VP of Life Sciences and ... a Pharmacist, Xavier was involved in his early career in the development of new ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. announced ... applications and services for use on Microsoft Azure. The customer experience management (CXM) ... online for a built-for-purpose customer engagement capability to use in their commercial or ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara Diagnostica is pleased to ... Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as ... quality and cost-efficient delivery. , For Research Use Only. Not for ...
(Date:4/7/2020)... LA JOLLA, Calif. (PRWEB) , ... April 06, 2020 , ... ... insight into their future children, reached 200,000 SneakPeek Early Gender DNA Tests ... , “ SneakPeek was launched as an ecommerce product, where a mom could ...
Breaking Biology Technology:
Cached News: